The Inflation Reduction Act of 2022 marked a significant shift in US health care policy, granting the Centers for Medicare and Medicaid Services (CMS) the authority to establish a program to negotiate ...

Regulatory reforms that improve the competitive landscape for biosimilars will promote drug affordability while incentivizing ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic.

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...

Records show that drug companies gave nearly $75,000 to the top Republican and Democrat on a committee investigating them.

At least three government lawyers working on defending a major Biden-era drug pricing law were laid off in mass cuts across ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...

A federal court rejected Novartis' legal challenge to the Medicare Drug Price Negotiation Program, ruling that it does not ...

Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...

Jon Stewart railed against sweeping cuts by the Department of Government Efficiency (DOGE) — and suffered one of his own in ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients without insurance.